List of PrimeVax Immuno-Oncology patents

Patent 11357795 was granted and assigned to PrimeVax Immuno-Oncology on June, 2022 by the United States Patent and Trademark Office.

Patent 10357553 was granted and assigned to PrimeVax Immuno-Oncology on July, 2019 by the United States Patent and Trademark Office.

Patent 9730989 was granted and assigned to PrimeVax Immuno-Oncology on August, 2017 by the United States Patent and Trademark Office.

Patent 10946080 was granted and assigned to PrimeVax Immuno-Oncology on March, 2021 by the United States Patent and Trademark Office.

Patent 9849167 was granted and assigned to PrimeVax Immuno-Oncology on December, 2017 by the United States Patent and Trademark Office.

Patent 10159727 was granted and assigned to PrimeVax Immuno-Oncology on December, 2018 by the United States Patent and Trademark Office.

Patent 10675304 was granted and assigned to PrimeVax Immuno-Oncology on June, 2020 by the United States Patent and Trademark Office.

Patent 10293038 was granted and assigned to PrimeVax Immuno-Oncology on May, 2019 by the United States Patent and Trademark Office.